Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HLA-E and HLA-F Are Overexpressed in Glioblastoma and HLA-E Increased After Exposure to Ionizing Radiation
Tomáš Hrbáč, Alena Kopková, František Siegl, et al.
Cancer Genomics & Proteomics (2022) Vol. 19, Iss. 2, pp. 151-162
Open Access | Times Cited: 17

Showing 17 citing articles:

Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
Jack G. Fisher, Amber D. P. Doyle, Lara Graham, et al.
Vaccines (2022) Vol. 10, Iss. 12, pp. 1993-1993
Open Access | Times Cited: 37
PACIFIC-9: Phase III trial of durvalumab + oleclumab or monalizumab in unresectable stage III non-small-cell lung cancer
Fabrice Barlési, Byoung Chul Cho, Sarah B. Goldberg, et al.
Future Oncology (2024) Vol. 20, Iss. 29, pp. 2137-2147
Open Access | Times Cited: 5
HPV16 infection promotes the malignant transformation of the esophagus and progression of esophageal squamous cell carcinoma
Hongzhou Zhao, Yuxuan Wei, Jiaying Zhang, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 10
Closed Access | Times Cited: 9
Deep Learning Glioma Grading with the Tumor Microenvironment Analysis Protocol for Comprehensive Learning, Discovering, and Quantifying Microenvironmental Features
Monika Pytlarz, Kamil Wojnicki, Paulina Pilanc, et al.
Deleted Journal (2024) Vol. 37, Iss. 4, pp. 1711-1727
Open Access | Times Cited: 3
Targeting HLA-E-overexpressing cancers with a NKG2A/C switch receptor
Michelle Sætersmoen, Ivan S. Kotchetkov, Lamberto Torralba‐Raga, et al.
Med (2024)
Open Access | Times Cited: 3
Targeting of Non-Classical Human Leukocyte Antigens as Novel Therapeutic Strategies in Cancer
Javier David Benítez Fuentes, Jorge Bartolomé, Kauzar Mohamed Mohamed, et al.
Cancers (2024) Vol. 16, Iss. 24, pp. 4266-4266
Open Access | Times Cited: 2
Killer instincts: natural killer cells as multifactorial cancer immunotherapy
Sarah Nersesian, Emily B. Carter, Stacey N. Lee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success
Galaxia M. Rodriguez, Edward Yakubovich, Barbara C. Vanderhyden
Cancers (2023) Vol. 15, Iss. 23, pp. 5694-5694
Open Access | Times Cited: 5
Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme
Luke C. Cooksey, Derek C. Friesen, Enrique D. Mangan, et al.
Cells (2024) Vol. 13, Iss. 18, pp. 1567-1567
Open Access | Times Cited: 1
HLA‐F transcriptional and protein differential expression according to its genetic polymorphisms
Julien Paganini, Pierre Faux, Sophie Beley, et al.
HLA (2023) Vol. 102, Iss. 5, pp. 578-589
Open Access | Times Cited: 3
Sequence Variations Within HLA-G and HLA-F Genomic Segments at the Human Leukocyte Antigen Telomeric End Associated With Acute Graft-Versus-Host Disease in Unrelated Bone Marrow Transplantation
Shingo Suzuki, Satoko Morishima, Makoto Murata, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5
Polymorphisms of Killer Ig-like Receptors and the Risk of Glioblastoma
Haeyoun Choi, In‐Cheol Baek, Soon A Park, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4780-4780
Open Access | Times Cited: 2
Diversity in the HLA-I Recognition of HLA-F Monoclonal Antibodies: HLA-F or HLA-Ib Monospecific, HLA-E or HLA-G Bispecific Antibodies with or without HLA-Ia Reactivity
Mepur H. Ravindranath, Narendranath M. Ravindranath, Carly J. Amato-Menker, et al.
Antibodies (2024) Vol. 13, Iss. 1, pp. 8-8
Open Access
IGF2BP2 orchestrates global expression and alternative splicing profiles associated with glioblastoma development in U251 cells
Wenqing Liu, Yan Liu, Haoyuan Li, et al.
Translational Oncology (2024) Vol. 51, pp. 102177-102177
Closed Access
Targeting HLA‐E in Lung Cancer: The Therapeutic Potential of IRF5‐Engineered M1‐Macrophage‐Derived Exosomes
Xuqin Feng, Xiangyu Lai, Mingming Zhou, et al.
The Clinical Respiratory Journal (2024) Vol. 18, Iss. 12
Closed Access
Deep Learning Glioma Grading with the Tumor Microenvironment Analysis Protocol for A Comprehensive Learning, Discovering, and Quantifying Microenvironmental Features
Monika Pytlarz, Kamil Wojnicki, Paulina Pilanc, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Targeting HLA-E Positive Cancers with a Novel NKG2A/C Switch Receptor
Michelle Sætersmoen, Ivan S. Kotchetkov, Lamberto Torralba‐Raga, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top